Key highlights
Explore more by category
Showing: 1 – 10 of 45 stories
08 March 2021 – 1 mins read
Statement on lanreotide European decentralised procedure
PARIS, FRANCE, 8 March 2021 – Ipsen has learned that Amdipharm Ltd, which is believed to be a subsidiary of Advanz Pharma, has received a positive outcome by the Reference Member State, Denmark, and closure of the Decentralised Procedure, for a generic f
01 March 2021 – 1 mins read
Ipsen announces the arrival of Gwenan White, EVP Communications & Public Affairs
We are pleased to announce the arrival of Gwenan White as Executive Vice President, Communications and Public Affairs, effective 1 March 2021. Based in Boulogne, France, she will be responsible for designing, implementing and managing the communications an
09 December 2020 – 1 mins read
Ipsen and the fight against corruption
Today is International Anti-Corruption Day. We are all aware that corruption has the potential to impact the social and economic development of all companies, societies and countries. That is why we must be unified in our efforts to conduct business with t
01 December 2020 – 2 mins read
Ipsen’s new strategic priorities unveiled at virtual Capital Markets Day event
Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy which positions us for long-term success by focusing together for patients and society. Four priorities will drive continued growth and bring transformative medicines to
26 November 2020 – 1 mins read
Ipsen – Capital Markets Day Webcast – Tuesday, December 1, 2020
David Loew, Chief Executive Officer, is pleased to host a Capital Markets Day webcast to present the Group’s Strategy on: